Suchergebnisse - "Chakraborty, Sweta"

PubPharm (12)

1

Pharmaceutical and medical device safety : a study in public and private regulation

Erschienen: München, C.H. Beck, 2019

Civil justice systems - volume 8

von Macleod, S. | Chakraborty, S.

2

The future of risk communication and the role of the pharmaceutical industry

enthalten in: Current drug safety | 2013

von Chakraborty, S. | Bouder, F.

3

Transparency and the Food and Drug Administration--a quantitative study

enthalten in: Journal of health communication | 2013

von Lofstedt, R. | Bouder, F. | Chakraborty, S.

4

The Future of Risk Communication and the Role of the Pharmaceutical Industry

enthalten in: Current drug safety | 2013

von Chakraborty, S. | Bouder, F.

5

Risk Communication and the Pharmaceutical Industry : what is the reality?

enthalten in: Drug safety | 2012

von Edwards, B. | Chakraborty, S.

6

Risk Communication and the Pharmaceutical Industry

enthalten in: Drug safety | 2012

von Edwards, B. | Chakraborty, S.

7

Transparency Initiative by the FDA's Center for Drug Evaluation and Research (CDER): Two qualitative studies of Public Perceptions

Erschienen: 2012

von Chakraborty, S. | Lofstedt, R.

8

The Role of Communication in Promoting a European Wide Approach to Risk Based Regulation

Erschienen: 2012

von Chakraborty, S.

9

Initial Phase Crisis Communications Following High Perceived Risk Events: The Volcanic Ash Crisis and the Japanese Tsunami as Examples

Erschienen: 2011

von Chakraborty, S. | Creutzfeldt-Banda, N.

10

Regulatory Transparency: Forthcoming Lessons from the FDA

Erschienen: 2010

von Chakraborty, S. | Lofstedt, R.